Real‐world effectiveness and safety of insulin glargine 300 U/ml in insulin‐naïve people with type 2 diabetes in the Latin America region: A subgroup analysis of the ATOS

por Vargas‐Uricoechea, Hernando, Burga Nuñez, José Luis, Rosas Guzmán, Juan, Silva‐Gomez, Liliana, Beltran, Sergio, Sañudo‐Maury, María Elena
Publicado 2022

Long-term changes in cardiovascular risk markers during administration of exenatide twice daily or glimepiride: results from the European exenatide study

por Simó, Rafael, Guerci, Bruno, Schernthaner, Guntram, Gallwitz, Baptist, Rosas-Guzmàn, Juan, Dotta, Francesco, Festa, Andreas, Zhou, Ming, Kiljański, Jacek
Publicado 2015